Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • PHASTAR Launches Pro-Bono Scheme for Charities

    Dec 7, 2022, 09:44 AM by
    PHASTAR, a global specialist biometrics contract research organization (CRO), has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data scientists, data managers and programmers at no cost.
    Full story
  • Cinchy Scores 5/5 For Product Vision Criterion In Major Enterprise Data Fabric Report

    Dec 7, 2022, 09:41 AM by
    Cinchy was rated ‘best product vision’ in the Forrester Wave for Enterprise Data Fabric, receiving the highest score in that category. The company is on a mission to simplify the way the world works with data. It streamlines the way data’s managed, accessed and used by organizations, and enables them to regain control while collaborating securely in real-time through a single network of interconnected data. It pioneers dataware, a new technology category that can be thought of as the next tech revolution following hardware and software. This essentially frees data from applications – a major advance and breakaway from a 40-year technology norm that required data to be integrated with each new application a company builds, taking up to half of entire IT budgets. See more in the announcement: https://cinchy.com/news/cinchy-scores-5/5-for-product-vision-criterion-in-major-enterprise-data-fabric-report and please let me know if I can provide anything further. Thanks, Amanda Schweitzer amanda@cdc.agency (845) 453-0026
    Full story
  • Recipharm announces extension of commercial manufacturing to support RedHill Biopharma’s Talicia® to 2026

    Dec 7, 2022, 09:38 AM by
    Global contract development and manufacturing organization (CDMO) Recipharm, today announced an extension of the ongoing commercial manufacturing of RedHill Biopharma’s (Nasdaq: RDHL) drug, Talicia® for the treatment of H. pylori infection, to 2026.
    Full story
  • Pharma and healthcare leaders discuss the innovations to fix our health system at Pharma Integrates 2022

    Dec 7, 2022, 09:25 AM by
    With the UK’s health system under pressure, leaders and innovators from across pharma and healthcare gathered at London Tower Bridge to discuss the future of the sector at the 11th annual Pharma Integrates event.
    Full story
  • Ohio Gastroenterology Adds Digital Pre- and Post-care Engagement Tools Through Orbita Platform

    Dec 6, 2022, 11:33 AM by
    Full story
  • MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease

    Dec 6, 2022, 11:32 AM by
    MultiOmic Health, an artificial intelligence-enabled precision medicine discovery company, today announces the signing of a research collaboration agreement with Northern Care Alliance (NCA) NHS Foundation Trust in Manchester, England.
    Full story
  • LogicStream Health and FDB Collaborate to Help Improve Management of Drug Shortages

    Dec 6, 2022, 11:31 AM by
    LogicStream Health and FDB Collaborate to Help Improve Management of Drug Shortages . LogicStream’s Drug Supply App™ now recommends therapeutic alternatives to minimize impact of drug supply disruptions
    Full story
  • Lonza’s API Mid-Scale Manufacturing Facility Expansion in Nansha Enters Commercial Operation

    Dec 6, 2022, 11:29 AM by
    Full story
  • Efforts Now Underway To Operationalize Exposomics

    Dec 6, 2022, 01:00 AM by User Not Found
    Bio-IT World | Truly implementing precision medicine requires that environmental exposures be factored into the equation. Mayo Clinic’s recent Individualizing Medicine Conference focused on exploring the exposome, the sum of external factors a person is exposed to across a lifetime.
    Full story
  • BRIM Biotechnology, Inc. raises $20 million in Series E funding round

    Dec 5, 2022, 10:51 AM by
    BRIM Biotechnology, Inc. ("BRIM," TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, announced today that it has raised $20 million in its Series E funding round. This demonstrates the heightened interest and growing demand for new treatments for Dry Eye Disease (DED).
    Full story
  • MIB Agents Awards $100,000 Grant for Pediatric Osteosarcoma Research at MD Anderson

    Dec 5, 2022, 10:50 AM by
    MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, has awarded a $100,000 research grant to Andy Livingston, M.D., a clinician and researcher in Sarcoma Medical Oncology and in Pediatric Oncology at The University of Texas MD Anderson Cancer Center. Ann Graham, Founder and Executive Director of MIB Agents, and Christina Ip-Toma, MIB Agents’ Director of Scientific Programs, presented the award to Dr. Livingston on Dec. 1 in Houston.
    Full story
  • AES Clean Technology launches OMNI™ Electric Utility Raceway

    Dec 2, 2022, 10:38 AM by
    This latest product is an innovative power and data management system that reduces risk and accelerates cleanroom delivery for the life sciences and pharmaceutical industry.
    Full story
  • REFERENCE MATERIALS FOR CALIBRATION VERIFICATION TESTING OF CHOLESTEROL ASSAYS NOW AVAILABLE FROM VERICHEM

    Dec 2, 2022, 10:37 AM by
    Full story
  • Emplicure AB and Quotient Sciences Announce an Integrated Manufacturing and Clinical Testing Partnership for Emplicure’s First Clinical Pharmacokinetic Study for EMPLI03

    Dec 2, 2022, 10:36 AM by
    Quotient Sciences, a global drug development and manufacturing accelerator, today announced a partnership with Emplicure, a Swedish pharmaceutical company focused on chronic pain and abuse-deterrent formulations.
    Full story
  • Foundational partnership with Paradigm4 enables Alnylam Pharmaceuticals to rapidly accelerate RNAi- based drug target discovery

    Dec 2, 2022, 10:33 AM by
    Full story
  • Digital Accessibility in the Life Sciences: Why Everyone Benefits from an Inclusive Industry

    Dec 2, 2022, 01:00 AM by User Not Found
    Bio-IT World | As digital transformation in the life sciences industry continues, the user experiences (UX) of researchers and scientists interacting with technology and data is coming under closer scrutiny. One area where attention is needed is the role of UX in improving digital accessibility. Better UX for all users will drive innovation, helping to make connections between data and accelerating collaboration.
    Full story
  • The Mobile Health/Central Lab Interface, an opportunity for DCT efficiency

    Dec 1, 2022, 09:49 AM by
    The Mobile Health/Central Lab Interface, an opportunity for DCT efficiency How streamlining relations between central labs and mobile health providers can get the most from hybrid and decentralised clinical trials
    Full story
  • Upgrading to FFP3 face masks in hospitals could save the NHS £360m a year and help slash patient waiting lists

    Dec 1, 2022, 09:47 AM by
    The NHS could save up to £360M per year by using FFP3 face masks – the NHS already has a large stockpile of these masks so there is no current need to purchase more. Independent studies commissioned by PPE manufacturer Globus Group and carried out by York Economic Health Consortium and Vital Economics confirm that these masks may be better at preventing respiratory infection and resulting staff days off.
    Full story
  • CD ComputaBio Introduces PyMOL Software for Bioinformatics Analysis

    Dec 1, 2022, 09:46 AM by
    Full story
  • Pronalyse’s Fusion Protein Characterization Service Aids in the Drug Development Process

    Dec 1, 2022, 09:34 AM by
    Full story
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127 (current)
  • 128
  • 129
  • 130
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy